[144] Sotera Health Company SEC Filing

Rhea-AI Filing Summary

Sotera Health Company (SHC) filing a Form 144 notifies the proposed sale of 126,611 shares of common stock through Charles Schwab with an aggregate market value of $2,040,969. The shares represent part of equity compensation originally acquired from the issuer on 11/20/2020 and are scheduled for sale approximately on 08/22/2025 on Nasdaq.

The filing discloses the number of shares outstanding as 284,046,606, and states there were no reported sales by the person in the past three months. The filer certifies they have no undisclosed material adverse information. This is a routine Rule 144 notice of an insider-proposed sale of previously issued equity compensation.

Positive

• None.

Negative

• Proposed insider sale of 126,611 shares valued at $2,040,969 is disclosed (a factual observation of insider selling).

Insights

Financial Analyst

TL;DR: Routine insider sale notice of equity compensation; size is small relative to total shares outstanding.

The Form 144 reports an intended sale of 126,611 shares valued at $2.04 million. Versus the reported 284.05 million shares outstanding, the sale equals approximately 0.045% of outstanding common stock, which is immaterial from a dilution or market-supply perspective. The securities were acquired as equity compensation on 11/20/2020 and the filing indicates no other sales in the prior three months. From a financial-impact standpoint, this notice is informational and unlikely to affect company valuation.

Corporate Governance Expert

TL;DR: Disclosure meets Rule 144 procedural requirements; the signer affirms absence of undisclosed material information.

The filing provides required broker, share count, acquisition date, and nature of acquisition (equity compensation). The signer’s certification that they are unaware of undisclosed material adverse information is standard language and relevant for compliance. No trading plan or 10b5-1 adoption date is indicated. Governance-wise, the notice documents regulator-compliant insider activity but does not reveal material corporate developments.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Charles Schwab & Co. 3000 Schwab Way Westlake TX 76262	126611	2040969.00	284046606	08/22/2025	Nasdaq

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	11/20/2020	Equity Compensation	Issuer			126611	11/20/2020	Services Rendered

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does Sotera Health's (SHC) Form 144 disclose?

The Form 144 discloses a proposed sale of 126,611 shares of common stock through Charles Schwab, with an aggregate market value of $2,040,969, approximately on 08/22/2025.

When were the shares that are being sold acquired?

The shares were acquired on 11/20/2020 as equity compensation from the issuer.

How many shares outstanding does the filing report for SHC?

The filing reports 284,046,606 shares outstanding.

Has the person sold SHC securities in the past three months?

The filing states Nothing to Report for securities sold during the past three months by the person for whose account the securities are to be sold.

Does the filing state any undisclosed material information about Sotera Health?

By signing, the person represents they do not know any material adverse information regarding the issuer that has not been publicly disclosed.